Literature DB >> 11592567

Insufficient adrenarche in patients with combined pituitary hormone deficiency caused by a PROP-1 gene defect.

A Voutetakis1, S Livadas, A Sertedaki, M Maniati-Christidi, C Dacou-Voutetakis.   

Abstract

Adrenarche was evaluated in five patients, aged 17.4 +/- 3 years, with combined pituitary hormone deficiency (CPHD), caused by a PROP-1 gene defect. Adrenocorticotrophic hormone (ACTH), cortisol and dehydroepiandrosterone sulfate (DHEAS) were determined prior to and following the administration of corticotropin-releasing hormone (CRH) in four of the five patients, while only basal values of ACTH, cortisol and DHEAS were determined in the fifth. In the four patients in whom a CRH test was carried out, the mean basal values of cortisol, ACTH and DHEAS were 289 +/- 140 nmol/l, 4.5 +/- 1.7 pmol/l and 0.26 +/- 0.36 micromol/l, respectively. The corresponding post-CRH peak values were 584 +/- 204 nmol/l, 12.7 +/- 3.9 pmol/l and 0.43 +/- 0.41 micromol/l. In the fifth patient, basal ACTH, cortisol and DHEAS values were 4 pmol/l, 411 nmol/l, and 2.33 micromol/l, respectively. Thus the basal and post CRH values of DHEAS (a marker of adrenarche) were low for age, while basal and post-CRH cortisol and ACTH values were within normal limits. For the interpretation of these findings two hypotheses can be proposed: 1) The PROP-1 gene is only expressed in the pituitary, and the role of PROP-1 is related to the maturation of the cells which synthesize the presumed adrenal androgen stimulating hormone (AASH). 2) The PROP-1 gene is also expressed in the adrenal cortex and, when defective, the zona reticularis does not function appropriately. Regardless of the interpretation

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11592567     DOI: 10.1515/jpem-2001-0806

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  2 in total

1.  Therapy-Induced Growth and Sexual Maturation in a Developmentally Infantile Adult Patient with a PROP1 Mutation.

Authors:  Ludmila Brunerova; Ivana Cermakova; Bozena Kalvachova; Jana Skrenkova; Renata Poncova; Petr Sedlak
Journal:  Front Endocrinol (Lausanne)       Date:  2017-11-13       Impact factor: 5.555

2.  Two coexisting heterozygous frameshift mutations in PROP1 are responsible for a different phenotype of combined pituitary hormone deficiency.

Authors:  K Ziemnicka; B Budny; K Drobnik; D Baszko-Błaszyk; M Stajgis; K Katulska; R Waśko; E Wrotkowska; R Słomski; M Ruchała
Journal:  J Appl Genet       Date:  2015-11-25       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.